Entries of Huber, Margit A. on the publication server
![]() | Up a level |
Number of items: 2.
van Akkooi, Alexander C. J., Haferkamp, Sebastian, Papa, Sophie, Franke, Viola, Pinter, Andreas, Weishaupt, Carsten, Huber, Margit A., Loquai, Carmen, Richtig, Erika, Gokani, Priya, Öhrling, Katarina, Louie, Karly S. and Mohr, Peter
(2021)
A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB–IVM1a Melanoma in Four European Countries.
Advances in Therapy 38 (2), pp. 1245-1262.
Fulltext not available.
Heppt, Markus V., Heinzerling, Lucie, Kähler, Katharina C., Forschner, Andrea, Kirchberger, Michael C., Loquai, Carmen, Meissner, Markus, Meier, Friedegund, Terheyden, Patrick, Schell, Beatrice, Herbst, Rudolf, Göppner, Daniela, Kiecker, Felix, Rafei-Shamsabadi, David, Haferkamp, Sebastian, Huber, Margit A., Utikal, Jochen, Ziemer, Mirjana, Bumeder, Irmgard, Pfeiffer, Christiane, Schäd, Susanne G., Schmid-Tannwald, Christoph, Tietze, Julia K., Eigentler, Thomas K. and Berking, Carola
(2017)
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
European Journal of Cancer 82, pp. 56-65.
Fulltext not available.
